During the past decade, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich" #1 collaborator was "State Hospital, St. Gallen" with 10 trials as a collaborator, "Swiss National Science Foundation" with 10 trials as a collaborator, "University of Geneva, Switzerland" with 10 trials as a collaborator, "University of Lausanne" with 10 trials as a collaborator and "University of Zurich" with 10 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich" are "Smoking Cessation" (10 trials), "COVID-19" (1 trials), "Cardiovascular Diseases" (1 trials), "Chikungunya" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich" in a lesser frequency.

Most popular intervention types in "Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich" are "Other" (12 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "ENDS (vaporizer/e-cig) and smoking cessation counseling" (9 trials), "Smoking cessation counseling" (9 trials), "COVID-19 Antibody testing" (1 trials), "ENDS (Vaporizer/e-cig) and smoking cessation counseling" (1 trials) and "No intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich" are 13 trials for "All" genders.

Currently, there are 12 active trials in "Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich". 1 are not yet recruiting, 1 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".